Ken Griffin Zoetis Inc. Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Zoetis Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 151,300 shares of ZTS stock, worth $25.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
151,300
Previous 287,300
47.34%
Holding current value
$25.3 Million
Previous $56.1 Million
56.08%
% of portfolio
0.0%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding ZTS
# of Institutions
2,058Shares Held
419MCall Options Held
1.22MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA41.4MShares$6.92 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$6.16 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.32 Billion0.13% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16MShares$2.68 Billion2.4% of portfolio
-
Morgan Stanley New York, NY11.8MShares$1.98 Billion0.14% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $78.3B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...